Why the study?
The study was conducted to investigate the association of mitral regurgitation with thromboembolic risk in patients with non-valvular atrial fibrillation undergoing TEE-guided cardioversion.
Does moderate or severe mitral regurgitation reduce left atrial appendage thrombus and stroke in patients with non-valvular atrial fibrillation undergoing TEE-guided cardioversion?
Does moderate or severe mitral regurgitation reduce left atrial appendage thrombus and stroke in patients with non-valvular atrial fibrillation undergoing TEE-guided cardioversion?
The presence or severity of mitral regurgitation does not decrease the risk of left atrial appendage thrombus or stroke in patients with non-valvular atrial fibrillation.
Answers are grounded in this paper and cite their sources.
Moderate/severe MR does not lower LAA thrombus or stroke risk; leaves open any protective effect in non-valvular AF.
OBJECTIVE: To investigate the association of mitral regurgitation (MR) on thromboembolic risk of patients with non-valvular atrial fibrillation (NVAF) undergoing transoesophageal echocardiography (TEE)-guided cardioversion. METHODS: Data for consecutive patients who underwent TEE-guided cardioversion for NVAF between 2000 and 2012 were analysed. MR severity was assessed by Doppler echocardiography and classified as ≤mild, moderate or severe. Left atrial appendage emptying velocities were averaged for five consecutive cycles. Multivariable regression models were used to identify independent predictors of left atrial appendage thrombus (LAAT) and stroke. Multivariable logistic regression analysis showed no association of moderate MR (OR 0.77, 95% CI 0.38 to 1.56) or severe MR (OR 0.55, 95% CI 0.21 to 1.49) with LAAT. During a mean follow-up of 7.3±5.1 years (median 7.5, IQR, 2.7-10.9), 216 patients had an ischaemic stroke. Adjusted Cox regression analysis showed no significant association of moderate MR (HR 1.22, 95% CI 0.88 to 1.68) or severe MR (HR 0.73, 95% CI 0.31 to 1.46) with stroke. CONCLUSIONS: Among patients with NVAF, the presence or severity of MR was not associated with a decreased risk of LAAT or stroke.
No takes yet. Share an insight, caveat, or question.
Melduni et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: